Insulet Corporation clinical trials
The registry lists 23 studies whose lead sponsor is Insulet Corporation. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 3, 2026.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 23studies on the registry
- 5open to participants now
- 6reach primary completion within a year
Get an email when these change. Save the Insulet Corporation studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Coming up
6 of Insulet Corporation’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.
Phase 3 Other phases
- NNov ’26’26
- 2DDec
- JJan ’27’27
- 1FFeb
- MMar
- AApr
- MMay
- 1JJun
- 1JJul
- AAug
- SSep
- OOct
- 1NNov
All 6
- Dec 2026Evaluation of the Fully Closed Loop Omnipod® System in Type 2 DiabetesNCT07521475
- Dec 2026Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1DNCT07593625
- Feb 2027Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 SystemNCT07579702
- Jun 2027Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 DiabetesNCT06144554
- Jul 2027French Prospective Multicentric Study in Real WorldNCT07039942
Show 1 moreShow fewer
- Nov 2027Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)NCT07317102
Add all 6 to your calendar (.ics) → With an account.
All 23 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 525
- 426
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Insulet Corporation.
- Insulet Corporation23 studiesSame company
Something wrong?
Focus areas
Conditions Insulet Corporation leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 23 of 23.
- Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1DRecruitingNCT07593625Not applicable
- Evaluation of the Fully Closed Loop Omnipod® System in Type 2 DiabetesRecruitingNCT07521475Not applicable
- Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)RecruitingNCT07317102
- Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 SystemRecruitingNCT07579702Not applicable
- Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 DiabetesRecruitingNCT06144554
- Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and AdultsCompletedNCT05923827Not applicable
- French Prospective Multicentric Study in Real WorldActive, not recruitingNCT07039942
- Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Adults With Type 2 DiabetesCompletedNCT07039981Not applicable
- An Evaluation of the Omnipod® M System in Adults With Type 2 DiabetesCompletedNCT07276776Not applicable
- Simplified Onboarding in Adults With Type 2 DiabetesCompletedNCT07070830Not applicable
- SmartAdjust 2.0 System With Type 1 and Type 2 DiabetesCompletedNCT06547918Not applicable
- Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 DiabetesCompletedNCT06865989Not applicable
- OP5-005 Using Omnipod 5 in Adults With Type 2CompletedNCT05815342Not applicable
- Omnipod 5 System Compared to Pump TherapyCompletedNCT05409131Not applicable
- Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 DiabetesCompletedNCT04617795Not applicable
- Pivotal Omnipod Horizon™ Automated Glucose Control SystemCompletedNCT04196140Not applicable
- Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 DiabetesCompletedNCT06181721Not applicable
- Omnipod Horizon™ Automated Glucose Control System Preschool CohortCompletedNCT04476472Not applicable
- Prepivotal Omnipod Horizon™ Automated Glucose Control SystemCompletedNCT04176731Not applicable
- Continuous Glucose Monitoring System (CGM)-Informed Bolus Calculator StudyCompletedNCT04320069Not applicable
- Insulet Artificial Pancreas Early Feasibility StudyCompletedNCT02897557Not applicable
- Insulet Artificial Pancreas Free-Living IDE3CompletedNCT03216460Not applicable
- Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2)CompletedNCT03064906Not applicable